“…When it comes to metabolic syndrome, as the signature of insulin resistance, in subjects confirmed with primary hyperparathyroidism, we identified ten studies [ 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 ] within the timeframe of research in addition to one study that was prior mentioned with respect to insulinoma analysis [ 111 ] and a cohort of primary hyperparathyroidism [ 28 ]. The overall results are still heterogeneous, and no clear conclusion can be drawn yet ( n = 10, N = 1010 subjects with primary hyperparathyroidism, among them, 193 individuals had normocalcemic/mild type [ 152 , 156 , 158 , 159 ]). Among them, there were six longitudinal studies upon parathyroidectomy (assessments were conducted after one, three, eight, twelve, and thirteen months) [ 151 , 153 , 156 , 157 , 158 , 160 ], for a total of 651 patients ( Table 7 ).…”